Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.

IF 3.1 2区 医学 Q2 CLINICAL NEUROLOGY Journal of Neuro-Oncology Pub Date : 2025-05-01 Epub Date: 2025-02-20 DOI:10.1007/s11060-025-04973-7
Hiska L van der Weide, Anne M Buunk, Femke F Siebenga, Johannes A Langendijk, Agata Bannink-Gawryszuk, Ingeborg Bosma, Roelien H Enting, Anouk van der Hoorn, Hanne-Rinck Jeltema, Michiel Wagemakers, Rob J M Groen, Annemiek M E Walenkamp-Hageman, Janine Nuver, Miranda C A Kramer, Jacoba M Spikman
{"title":"Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.","authors":"Hiska L van der Weide, Anne M Buunk, Femke F Siebenga, Johannes A Langendijk, Agata Bannink-Gawryszuk, Ingeborg Bosma, Roelien H Enting, Anouk van der Hoorn, Hanne-Rinck Jeltema, Michiel Wagemakers, Rob J M Groen, Annemiek M E Walenkamp-Hageman, Janine Nuver, Miranda C A Kramer, Jacoba M Spikman","doi":"10.1007/s11060-025-04973-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To determine neurocognitive function (NCF) profiles of patients with lower grade glioma (LGG) eligible to undergo proton radiotherapy (PRT), and how these relate to clinical and radiological characteristics. PRT is offered to those patients for whom sparing of NCF is considered important given their favorable prognosis. To date it is unknown to which extent their NCF profiles are favorable as well.</p><p><strong>Methods: </strong>A consecutive cohort of 151 LGG patients eligible for PRT according to prevailing Dutch criteria, referred between 2018 and 2023, were assessed with standardized neuropsychological tests prior to PRT. Scores were compared to norm-scores. Composite scores were calculated for the total NCF and 6 separate cognitive domains, and profiles were related to tumor location. Clinical and radiological factors characterizing overall NCF impaired patients were investigated, comparing 3 definitions for impairment.</p><p><strong>Results: </strong>Patients had on average significantly lower NCF than their norm-group, but interindividual variability was large. For 100/151 patients (66.2%), all cognitive domains were intact, whereas 15/151 patients (9.9%) displayed multiple domain impairments. Poorer NCF was related to right-sided LGG laterality, larger PRT target volume, no Wait & Scan policy, worse neurological function and worse radiological indices (Fazekas and global cortical atrophy, respectively). LGG involvement of the left temporal and occipital lobes was associated with, respectively, lower verbal memory and processing speed.</p><p><strong>Conclusion: </strong>Prior to PRT, the majority of selected LGG patients display favorable NCF profiles. However, a subgroup showed NCF impairments, with multiple relevant clinical and radiological covariates.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"147-156"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041185/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-025-04973-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To determine neurocognitive function (NCF) profiles of patients with lower grade glioma (LGG) eligible to undergo proton radiotherapy (PRT), and how these relate to clinical and radiological characteristics. PRT is offered to those patients for whom sparing of NCF is considered important given their favorable prognosis. To date it is unknown to which extent their NCF profiles are favorable as well.

Methods: A consecutive cohort of 151 LGG patients eligible for PRT according to prevailing Dutch criteria, referred between 2018 and 2023, were assessed with standardized neuropsychological tests prior to PRT. Scores were compared to norm-scores. Composite scores were calculated for the total NCF and 6 separate cognitive domains, and profiles were related to tumor location. Clinical and radiological factors characterizing overall NCF impaired patients were investigated, comparing 3 definitions for impairment.

Results: Patients had on average significantly lower NCF than their norm-group, but interindividual variability was large. For 100/151 patients (66.2%), all cognitive domains were intact, whereas 15/151 patients (9.9%) displayed multiple domain impairments. Poorer NCF was related to right-sided LGG laterality, larger PRT target volume, no Wait & Scan policy, worse neurological function and worse radiological indices (Fazekas and global cortical atrophy, respectively). LGG involvement of the left temporal and occipital lobes was associated with, respectively, lower verbal memory and processing speed.

Conclusion: Prior to PRT, the majority of selected LGG patients display favorable NCF profiles. However, a subgroup showed NCF impairments, with multiple relevant clinical and radiological covariates.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
选择质子放疗的低度胶质瘤患者的神经认知功能:来自前瞻性队列研究的真实世界数据。
目的:确定适合接受质子放疗(PRT)的低级别胶质瘤(LGG)患者的神经认知功能(NCF)特征,以及这些特征与临床和放射学特征的关系。PRT提供给那些认为保留NCF很重要的患者,因为他们的预后良好。到目前为止,还不清楚它们的NCF分布在多大程度上是有利的。方法:在2018年至2023年期间,对151例符合荷兰现行标准的LGG患者进行连续队列研究,在PRT之前进行标准化神经心理测试。将分数与标准分数进行比较。计算总NCF和6个独立认知域的综合评分,并计算与肿瘤位置相关的概况。研究了表征NCF整体受损患者的临床和放射学因素,比较了3种损伤定义。结果:患者的NCF平均显著低于正常组,但个体间差异较大。100/151例患者(66.2%)所有认知域完好,15/151例患者(9.9%)出现多域损伤。较差的NCF与右侧LGG偏侧、较大的PRT靶体积、无等待扫描策略、较差的神经功能和较差的放射学指标(分别为Fazekas和全局皮质萎缩)有关。左颞叶和枕叶的LGG受损伤分别与较低的言语记忆和处理速度有关。结论:在PRT之前,大多数选择的LGG患者表现出良好的NCF特征。然而,一个亚组显示NCF损伤,具有多个相关的临床和放射学协变量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
期刊最新文献
[18F]FET-PET in dissecting low-grade oligodendrogliomas. Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI. T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity. Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy. Advances in imaging modalities and tumor classification for vestibular schwannomas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1